Prot # A3921053: An Observational Study to Collect Follow-Up Clinical Data from Kidney Transplant Recipients Who Received Tofacitnib(CP-690,550) in Completed Phase 2 Studies

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/11 → 7/27/14

Funding

  • ICON Clinical Research, LLC (Prot # A3921053)
  • Pfizer Inc. (Prot # A3921053)